Further investigation of blockade effects and binding affinities of selected natural compounds to immune checkpoint pd-1/pd-l1

HIGHLIGHTS

• who: Huifang Li from the Xiangya Hospital, Central University, China have published the research: Further investigation of blockade effects and binding affinities of selected natural compounds to immune checkpoint PD-1/PD-L1, in the Journal: (JOURNAL)
• what: A combination of a PD-1/PD-L1 blockade assay (pair ELISA) and a target-binding assay (SPR) was used to screen the PD-1/PDL1 blockade effect of a series of natural compounds.
• how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.